The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines. (Q51835932)
Jump to navigation
Jump to search
scientific article published in September 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines. |
scientific article published in September 2003 |
Statements
1 reference
The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines. (English)
1 reference
Rino Rappuoli
1 reference
Barbara C Baudner
1 reference
Marzia M Giuliani
1 reference
J Coos Verhoef
1 reference
Hans E Junginger
1 reference
Giuseppe Del Giudice
1 reference
1 September 2003
1 reference
1 reference
21
1 reference
3837-3844
1 reference
25-26
1 reference
Identifiers
1 reference